UNSPSC 51162735: Naphazoline nitrate

This classification denotes an alpha-adrenergic agonist with the molecular formula C14H14N2.HNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SC99GR1T5S, chemically known as 2-imidazoline, 2-(1-naphthylmethyl)-, mononitrate but more generally known as naphazoline nitrate, which bears US NIH Compound Identifier 21225. European Medicines Agency schedules Naphazoline nitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03390MIG.

Most nations, for tariff and trade purposes, schedule naphazoline nitrate under HS 29332990 and SITC 51573. Naphazoline Nitrate bears US NLM identifiers UMLS ID C0770988 and NCI Concept Code C98243. As of Q4 2014, NAPHAZOLINE NITRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC2C(C1)CCCC2CC3=NCCN3.[N+](=O)(O)[O-].

UNSPSC 51162735 Naphazoline nitrate is a Commodity code that encompasses pharmaceutical products and over-the-counter medications procured by state and local health agencies, though recent opportunities under this code tag demonstrate substantial mismatch with the nominal scope — state and local solicitations recently posted under this code primarily target naloxone (an opioid antagonist), safe drug deactivation systems, and multi-source generic pharmaceuticals and OTC products rather than naphazoline nitrate specifically. Issuing bodies include county health departments (Seminole County, Florida), state procurement offices acting through cooperative purchasing vehicles (Minnesota Department of Administration through the Minnesota Multistate Cooperative Purchasing Alliance), and participating state and local government facilities across multiple states. The work involves procurement of finished pharmaceutical products for community health initiatives, emergency response programs, and routine healthcare operations, with vendors responsible for supply chain compliance including cGMP certification, FDA compliance, Drug Supply Chain Security Act adherence, and delivery logistics.

Recent activity spans Florida and Minnesota-led multi-state cooperative purchasing. Seminole County, Florida issued IFB 60459723LAS (due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, with fixed-fee pricing and potential FEMA funding. The Minnesota Department of Administration's Office of State Procurement issued RFP S1070000015802 (due March 26, 2026) on behalf of MMCAP to establish multi-vendor contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota, Oregon, and other participating jurisdictions, with awarded vendors effective July 1, 2026 and pricing weighted 75 percent on competitiveness. Both solicitations require E-Verify compliance, comprehensive insurance coverage, and submission through electronic procurement systems.